Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Liposarcoma, Myxoid 1Liposarcoma 1

Interventions

Cyclophosphamide 13fludarabine 7Trabectedin 4Radiation Dose Hypofractionation 3seclidemstat 2pembrolizumab 2Topotecan 2Interferon-gamma 2selinexor 1ribociclib 1pazopanib 1palbociclib 1mirdametinib 1itacitinib 1interferon gamma-1b 1fludarabine phosphate 1cytochrome C synthetase 1brostallicin 1baricitinib 1atezolizumab 1aldesleukin 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Radiotherapy 1Radiation 1Proton Therapy 1Pioglitazone 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma, Myxoid × mirdametinib × Sarcoma × Clear all
NCT06843967 2026-05-22

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
54 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡